Design, synthesis, and biological evaluation of novel 2-Methylpiperazine (cas 109-07-9) derivatives as potent CCR5 antagonists
-
Add time:08/22/2019 Source:sciencedirect.com
Three series of novel 2-Methylpiperazine (cas 109-07-9) derivatives were designed and synthesized using a fragment-assembly strategy. Among them, six compounds (13, 16, 18, 22, 33, and 36) showed potent activity against CCR5 comparable to that of the positive control, maraviroc, in calcium mobilization assay. Moreover, some compounds were selected and further tested for their antiviral activity in HIV-1 single cycle assay. As a result, four compounds (13, 16, 33, and 36) showed antiviral activity at the nanomolar level. Additionally, the potent four compounds showed no cytotoxicity at a concentration of 10 μM.
We also recommend Trading Suppliers and Manufacturers of 2-Methylpiperazine (cas 109-07-9). Pls Click Website Link as below: cas 109-07-9 suppliers
Prev:Characterization and kinetics of CO2 absorption in potassium carbonate solution promoted by 2-Methylpiperazine (cas 109-07-9)
Next:Thermodynamic and Kinetic Modeling of Piperazine/2-Methylpiperazine (cas 109-07-9)☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Thermodynamic and Kinetic Modeling of Piperazine/2-Methylpiperazine (cas 109-07-9)☆08/23/2019
- Characterization and kinetics of CO2 absorption in potassium carbonate solution promoted by 2-Methylpiperazine (cas 109-07-9)08/21/2019
- Theoretical study of CO2 separation from CO2/CH4 gaseous mixture using 2-Methylpiperazine (cas 109-07-9) -promoted potassium carbonate through hollow fiber membrane contactor08/20/2019
- Effects of Viscosity on CO2 Absorption in Aqueous Piperazine/2-Methylpiperazine (cas 109-07-9)☆08/19/2019